Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (21)

2022

  1. Characterization of Early Peripheral Immune Responses in Patients with Sepsis and Septic Shock

    Biomedicines, Vol. 10, Núm. 3

  2. Therapeutic Strategies Targeting Mitochondrial Calcium Signaling: A New Hope for Neurological Diseases?

    Antioxidants, Vol. 11, Núm. 1

  3. Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Cofilin and neurodegeneration: New functions for an old but gold protein

    Brain Sciences, Vol. 11, Núm. 7

  2. Comparative analysis of chromatin-delivered biomarkers in the monitoring of sepsis and septic shock: A pilot study

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  3. Role of microRNAs As Biomarkers in Sepsis-Associated Encephalopathy

    Molecular Neurobiology, Vol. 58, Núm. 9, pp. 4682-4693

  4. Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis

    Progress in Cardiovascular Diseases, Vol. 68, pp. 70-77

  5. Use of Two Complementary Bioinformatic Approaches to Identify Differentially Methylated Regions in Neonatal Sepsis

    Open Bioinformatics Journal, Vol. 14, Núm. 1, pp. 144-152

2020

  1. Circular RNAs in Sepsis: Biogenesis, Function, and Clinical Significance

    Cells, Vol. 9, Núm. 6

  2. Epigenetic biomarkers for human sepsis and septic shock: Insights from immunosuppression

    Epigenomics, Vol. 12, Núm. 7, pp. 617-646

  3. Oxidative stress and inflammation in covid-19-associated sepsis: The potential role of anti-oxidant therapy in avoiding disease progression

    Antioxidants, Vol. 9, Núm. 10, pp. 1-20

  4. Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich’s ataxia

    Antioxidants, Vol. 9, Núm. 12, pp. 1-25

2019

  1. Oxidative post-translational modifications in histones

    BioFactors, Vol. 45, Núm. 5, pp. 641-650

  2. Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich’s Ataxia Mouse Model

    Neurotherapeutics, Vol. 16, Núm. 2, pp. 432-449

2018

  1. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening

    Redox Biology, Vol. 14, pp. 398-408

2017

  1. A new mass spectrometry-based method for the quantification of histones in plasma from septic shock patients

    Scientific Reports, Vol. 7, Núm. 1

  2. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory

    Critical Reviews in Clinical Laboratory Sciences, Vol. 54, Núm. 7-8, pp. 529-550

  3. Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells

    Journal of Cellular and Molecular Medicine, Vol. 21, Núm. 8, pp. 1584-1592

2016

  1. Circulating Histones and Nucleosomes as Biomarkers in Sepsis and Septic Shock

    Epigenetic Biomarkers and Diagnostics (Elsevier Inc.), pp. 497-517

2015

  1. Increased Oxidative Stress and Impaired Antioxidant Response in Lafora Disease

    Molecular Neurobiology, Vol. 51, Núm. 3, pp. 932-946